scienceresolvedAI generated
Will the New England Journal of Medicine (NEJM) publish a phase 3 clinical trial result for a novel oncology drug between April 27–May 3, 2026?
A phase 3 randomized controlled trial with a primary focus on a novel oncology (cancer treatment) drug appears in NEJM with a publication date of April 27–May 3, 2026 Source: New England Journal of Medicine at nejm.org
Resolved: YES
Market Overview
YES — 50%NO — 50%
YES Odds
2x
NO Odds
2x
Total Volume
0
Bettors
0
Details
Resolution DateMay 4, 2026
Resolution SourceNew England Journal of Medicine at nejm.org
Total Bets0
YES Pool0 tokens
NO Pool0 tokens
Created4/19/2026
Recent Bets
No bets placed yet. Be the first!